Morgan Lewis

Related News

12/14/10 Morgan Lewis Advises TransForce in $248M Acquisition of Dynamex
TransForce Inc., the leader in the Canadian transportation and logistics industry, has entered into a definitive agreement and plan of merger to acquire all of the outstanding shares of Dynamex Inc. for a purchase price of $25.00 per share, in cash, representing a total purchase price of approximately US $248 Million.
09/16/10 Morgan Lewis Advises United Business Media on $287 Million Acquisition of Canon Communications
Today, United Business Media Limited (UBM) announced that it will acquire Canon Communications LLC for $287 million. Morgan Lewis advised UBM on the transaction.
05/20/10 Morgan Lewis Advises Toyota on Agreement with Tesla to Jointly Develop Electric Vehicles
TESLA MOTORS, INC. (Tesla) and TOYOTA MOTOR CORPORATION (TMC) today announced that they intend to cooperate on the development of electric vehicles, parts, and production system and engineering support.
View all news
Photo of  Jonathan D. Morris

honors + affiliations

Managing Editor, University of Michigan Journal of Law Reform

bar admissions

  • New York
print profile

Jonathan D. Morris
Partner


Email: jmorris@morganlewis.com
New York
101 Park Avenue
New York, NY 10178-0060
Phone: 212.309.6636
Fax: 212.309.6001

Jonathan D. Morris is a partner in Morgan Lewis's Business and Finance Practice, a member of the firm's Private Equity Practice and Mergers and Acquisitions Practice, and vice-chairman of the recruiting committee for the New York office. Mr. Morris's practice focuses on domestic and cross-border mergers and acquisitions. He also advises clients on joint ventures, strategic alliances, private placements, and general corporate and compliance matters.

Mr. Morris has been involved in a wide range of transactions, including domestic and cross-border acquisitions and sales of both publicly and privately held corporations, and has represented both strategic and financial acquirers and targets. He has advised clients across numerous industries, including media, financial services, food and beverage, retail, infrastructure, building materials, and consumer products.

Mr. Morris is admitted to practice in New York.

Selected Representations

  • Apollo Management in its $3 billion acquisition of Claire's Stores
  • Apollo Management in its $1 billion acquisition of CKE Restaurants
  • Leo Pharma in connection with its $1 billion acquisition of certain products and related distribution rights from Warner Chilcott
  • Sierra Health Services in its $2.5 billion sale to UnitedHealth
  • Quintana Maritime in its $2.45 billion sale to Excel Maritime Carriers
  • Pearson Education in its $540 million acquisition of eCollege.com
  • Sun Capital Partners in its $340 million acquisition of Friendly Ice Cream Corporation
  • TransForce in its $248 million acquisition of Dynamex
  • Sekisui Chemical Co., Ltd. in its $173 million acquisition of Celanese's polyvinyl alcohol business
  • Toyota Motor Corporation in its $50 million investment in, and joint alliance with, Tesla Motors for the future production of electric vehicles
  • A group of investors including Morgan Stanley, Knight Capital, the International Securities Exchange, and Susquehanna Growth Equity in their investment in Ballista Alternative Trading
  • Morgan Stanley in the sale of its ownership interest in the Philadelphia Stock Exchange to NASDAQ
  • Morgan Stanley in its acquisition of a minority interest in Kapow Technologies
  • Highstar Capital in its acquisition of an automobile port operator
  • Kraft Foods in the sale of its Balance Bar business
  • United Business Media in its acquisitions of Canon Communications, Techonline, Shorecliff Communications, U.S. Newswire, Portelligent, and Vision Events
  • Dr Pepper/Seven Up Bottling Group in the acquisition of several independent bottlers and distributors
  • Rocket Marine in its transfer of majority voting control of Aries Maritime Transport through voting and lockup agreements with Grandunion.
  • Biovail Corporation in its acquisition of Prestwick Pharmaceuticals

education

  • University of Michigan Law School, 1998, J.D.
  • University of Pennsylvania, 1995, B.A.